Uniforce Technology (7714.TWO) Earnings Analysis

Uniforce Technology (7714.TWO) next reports earnings on 2026-09-02, consensus EPS 1.89 TWD. Last quarter (2026-05-08) it beat with EPS 1.58 TWD vs 1.25 TWD est (+26.4%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 25.73.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 7714.TWO next report earnings?

Next earnings date2026-09-02
Consensus EPS estimate1.89 TWD
Revenue estimate0.52B

7714.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-081.58 TWD1.25 TWD+26.4%Beat
2026-03-022.05 TWD2.05 TWD0%Beat
2025-11-071.77 TWD1.77 TWD0%Beat
2025-08-081.54 TWD1.54 TWD0%Beat
2025-05-121.02 TWD0.7 TWD+45.7%Beat
2025-03-052.35 TWD2.12 TWD+10.8%Beat
2024-09-300.96 TWDn/an/an/a

Beat rate: 6/6 (100%) over reported quarters with consensus data.

7714.TWO valuation and analyst view

Trailing P/E25.73
Trailing EPS6.873 TWD
Price / book7.03
Dividend yield2.82%
Market cap3.86B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Uniforce Technology (7714.TWO)'s next earnings date?

Uniforce Technology is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 1.89 TWD and revenue estimate of 0.52B.

Did 7714.TWO beat earnings last quarter?

In its 2026-05-08 report, 7714.TWO posted EPS of 1.58 TWD versus a 1.25 TWD estimate — a beat of 26.4%.

What is 7714.TWO's earnings track record?

Over the last 6 reported quarters with consensus data, 7714.TWO beat estimates 6 times (100%).

What is 7714.TWO's current P/E ratio and EPS?

7714.TWO trades at a trailing P/E of 25.73 on trailing EPS of 6.8732897935834485 TWD.

What do analysts rate 7714.TWO?

7714.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.